Jennifer Turano, OD
Optometrist · Wilmington, DENPI 1770963449
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $25,857 of the $41,609 with a category attached, or 62.1%. Alcon accounts for 83.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $14,529 and has fallen 91.9% since, to $1,184 in 2025. Among optometrist clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $286.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$35K
- Carl Zeiss Meditec, Inc.$4K
- Carl Zeiss Meditec USA, Inc.$2K
- Bausch & Lomb Americas Inc.$401
- Valley Contax, Inc.$160
- Kala Pharmaceuticals, Inc.$134
- plus $665 from 13 others
What the payments were for
- Consulting fees$25,85762%
- Speaking & faculty fees$6,84516%
- Travel & lodging$3,6309%
- Food & beverage$5,08112%
- Gifts$1970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 81 | $34,800 |
| Carl Zeiss Meditec, Inc. | 12 | $3,675 |
| Carl Zeiss Meditec USA, Inc. | 13 | $1,774 |
| Bausch & Lomb Americas Inc. | 6 | $401 |
| Valley Contax, Inc. | 1 | $160 |
| Kala Pharmaceuticals, Inc. | 2 | $134 |
| Johnson & Johnson Vision Care, Inc. | 7 | $125 |
| Dompe US, Inc. | 3 | $98 |
| Sun Pharmaceutical Industries Inc. | 4 | $97 |
| AbbVie | 3 | $72 |
| Novartis | 3 | $61 |
| Biotissue Holdings Inc. | 2 | $46 |
| Oyster Point Pharma, Inc. | 2 | $35 |
| Mallinckrodt Enterprises LLC | 1 | $28 |
| Haag-streit USA, Inc. | 1 | $24 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Synergeyes, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Coopervision Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOTAL30$15,644
- DAILIES TOTAL1$7,627
- DAILIES$5,866
- Precision 1$4,952
- CLARUS$2,750
- FORUM$2,610
- Humphrey HFA$1,997
- CIRRUS HD-OCT$1,732
- Humphrey Field Analyzer (HFA3)$1,000
- CLARUS 500 Fundus Camera$610
- FORUM Glaucoma Workplace$600
- ILUX$570
- MIEBO$264
- XIIDRA$264
- Systane$190
- CIRRUS 5000$180
- CLARUS 500$155
- CIRRUS 6000 with AngioPlex$150
- ATLAS 500$150
- EYSUVIS$122
How this compares
$41,609 in reported general payments places this provider in the 95th percentile of 146 optometrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 33 | $64,051 |
| RestasisCyclosporine | 16 | $23,817 |
| MieboPerfluorohexyloctane/Pf | 15 | $17,473 |
| Latanoprost | 60 | $1,089 |
| Brimonidine Tartrate | 11 | $561 |
| Timolol Maleate | 19 | $323 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 14 | $206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $401 | $81,52448 claims |
| AbbVieRestasis | $72 | $23,81716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 146 optometrist providers in Delaware.
Other optometrist in Wilmington
- Laura GoldbergWilmington$17K
- Lea MenearWilmington$4K
- Lorna SimmermanWilmington$4K
- Alissa LongWilmington$4K
- Scott TucciWilmington$3K
- Sarah Nowicki-DuczeminskiWilmington$3K
- Daniel BaruffiWilmington$2K
- Jamie WohlhagenWilmington$2K
- Leanne HeuerWilmington$2K
- Alex QuachWilmington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.